CLINICAL_TRIALS
trial_result
· 2025-04-25
Clinical Trial Update: Descartes-11 in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
Summary
Phase 1 study of Descartes-11 in relapsed/refractory multiple myeloma was terminated, with results posted on 2025-04-25.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cartesian Therapeutics | Conditions: Multiple Myeloma | Phase 1 | Status: TERMINATED | Results posted: 2025-04-25